Challenge
Lonza’s Clients required Biopharmaceutical manufacturing capacity in order to meet pilot and launch quantities of drugs for chronic ailments. To de-risk lower than forecast sales, greater attrition between phase 3, and launch scale, and process changes resulting from improved manufacturing yield Lonza’s Clients were urgently seeking contract manufacturers who had flexibility and capacity.
Solution
Bob lead a strategic team to create a portfolio of projects which would meet this need. The projects were:
Result
Implementing this strategic plan and delivering the projects achieved: